Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
FSI-189 is an antibody that targets SIRPA and inhibits the interaction between SIRPA and CD47 on tumor cells, which may lead to the activation of macrophages and phagocytic activity of tumor cells (NCI Drug Dictionary).
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|FSI-189 + Rituximab||FSI-189 Rituximab||0||1|